5-beta stereoselective reductions of 3-ketochol-4-enoic acid and derivatives thereof

EP4762187A1Pending Publication Date: 2026-06-24SANDHILL ONE LLC

Patent Information

Authority / Receiving Office
EP · EP
Patent Type
Applications
Current Assignee / Owner
SANDHILL ONE LLC
Filing Date
2024-09-11
Publication Date
2026-06-24

AI Technical Summary

Technical Problem

Current methods for synthesizing cholic acid derivatives are cumbersome and inefficient, often resulting in significant amounts of 5-alpha impurities during the reduction of the 4,5-double bond in 3-keto-chol-4-enoic acids.

Method used

The development of novel enzymatic and catalytic methods to reduce the 4,5-double bond of 3-keto-chol-4-enoic acids, preferentially producing 5-beta products, using enzymes such as At5pStR or its analogs with high sequence identity, and employing reaction conditions suitable for hydrogenation catalysts in trickle bed reactors.

Benefits of technology

These methods achieve high stereoselectivity and efficiency in producing cholic acid derivatives like ursodeoxycholic acid (UDCA) and tauroursodeoxycholic acid (TUDCA), with reduced 5-alpha impurities, thereby improving the overall process efficiency.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure US2024046051_20032025_PF_FP_ABST
    Figure US2024046051_20032025_PF_FP_ABST
Patent Text Reader

Abstract

Methods of making steroids, methods of making 5β stereoselective reductions of steroids; and steroids produced by said 5β stereoselective reduction.
Need to check novelty before this filing date? Find Prior Art